Partnership Forum: Implementing value-based reimbursement models for both pharmaceuticals and medical care poses significant challenges and opportunities, and depends on integrated delivery networks (IDNs) to execute the processes and programs. Industry thought leaders convened to discuss the issues.
Conclusions reached in a recent New York Times article on outcomes-based contracting are premature, if not inaccurate, stated Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, adding, “It’s still the early innings for outcomes-based, or value-based, contracting for prescription drugs, and therefore, too soon to dismiss.”
Press Release: Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of “value-based contracting.”
Partnership Forum: On December 2, 2014, AMCP brought together 60 health care executives from across the nation for a full day of dialogue on critical issues facing the health care system.